VAXX
Income statement / Annual
Last year (2023), Vaxxinity, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2023, Vaxxinity, Inc.'s net income was -$56.93 K.
See Vaxxinity, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$0.00 |
$0.00 |
$66.00 K |
$557.00 K |
$0.00 |
| Cost of Revenue |
$2.23 M
|
$1.68 M
|
$1.94 M
|
$52.00 K
|
$107.00 K
|
| Gross Profit |
-$2.23 M
|
-$1.68 M
|
-$1.87 M
|
$505.00 K
|
-$107.00 K
|
| Gross Profit Ratio |
0
|
0
|
-28.35
|
0.91
|
0
|
| Research and Development Expenses |
$33.67 M
|
$47.63 M
|
$71.38 M
|
$20.57 M
|
$10.66 M
|
| General & Administrative Expenses |
$22.39 M
|
$28.35 M
|
$51.83 M
|
$12.22 M
|
$3.01 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$22.39 M
|
$28.35 M
|
$51.83 M
|
$12.22 M
|
$3.01 M
|
| Other Expenses |
$0.00
|
-$1.68 M
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$56.05 M
|
$74.30 M
|
$123.20 M
|
$32.79 M
|
$13.66 M
|
| Cost And Expenses |
$58.29 M
|
$75.98 M
|
$125.14 M
|
$32.84 M
|
$13.66 M
|
| Interest Income |
$2.09 M
|
$1.26 M
|
$9.00 K
|
$0.00
|
$435.00 K
|
| Interest Expense |
$696.00 K
|
$514.00 K
|
$840.00 K
|
$1.18 M
|
$435.00 K
|
| Depreciation & Amortization |
$2.23 M
|
$1.68 M
|
$1.10 M
|
$717.00 K
|
$107.00 K
|
| EBITDA |
-$54.00 M |
-$73.02 M |
-$135.23 M |
-$38.06 M |
-$13.58 M |
| EBITDA Ratio |
0
|
0
|
-2048.98
|
-68.33
|
0
|
| Operating Income Ratio |
0
|
0
|
-1895.08
|
-57.96
|
0
|
| Total Other Income/Expenses Net |
$1.35 M
|
$757.00 K
|
-$12.10 M
|
-$7.68 M
|
-$502.00 K
|
| Income Before Tax |
-$56.93 K
|
-$75.22 M
|
-$137.18 M
|
-$39.96 M
|
-$14.16 M
|
| Income Before Tax Ratio |
0
|
0
|
-2078.41
|
-71.74
|
0
|
| Income Tax Expense |
$0.00
|
-$12.00 K
|
$0.00
|
$0.00
|
$56.00 K
|
| Net Income |
-$56.93 K
|
-$75.21 M
|
-$137.18 M
|
-$39.96 M
|
-$14.22 M
|
| Net Income Ratio |
0
|
0
|
-2078.41
|
-71.74
|
0
|
| EPS |
-0.0005 |
-0.6 |
-1.09 |
-0.32 |
-0.11 |
| EPS Diluted |
-0.0005 |
-0.6 |
-1.09 |
-0.32 |
-0.11 |
| Weighted Average Shares Out |
$126.51 M
|
$125.94 M
|
$125.39 M
|
$125.45 M
|
$125.45 M
|
| Weighted Average Shares Out Diluted |
$126.51 M
|
$125.94 M
|
$125.39 M
|
$125.45 M
|
$125.45 M
|
| Link |
|
|
|
|
|
